Ambry Genetics Launches A New Generation Of Clinical Exome Sequencing
3/27/2014 9:32:24 AM
More...
|
Ambry Genetics Prevails In Preliminary Injunction Motion Filed By Myriad Genetics, Inc. (MYGN)
3/11/2014 9:02:34 AM
More...
|
Court Denies Myriad Genetics, Inc. (MYGN)' Motion To Block Rival Ambry Genetics
3/11/2014 7:21:19 AM
More...
|
Gene By Gene Rejects BRCA1/2 Patent Infringement Claims by Myriad Genetics, Inc. (MYGN) and Joins Ambry Genetics to Sue Myriad for Violating Federal Antitrust Laws
8/15/2013 7:12:46 AM
More...
|
Ambry Genetics Sues Myriad Genetics, Inc. (MYGN) for Violating Federal Antitrust Laws
8/6/2013 6:38:10 AM
More...
|
Ambry Genetics Reaffirms Status as Worldwide Leader in Hereditary Cancer Testing With New Renal, Pancreatic and PGL-PCC Panels
8/1/2013 11:24:55 AM
More...
|
Ambry Genetics Will Vigorously Defend Against BRCA1 and BRCA2 Gene Patent Infringement Suit
7/11/2013 10:24:04 AM
More...
|
Myriad Genetics, Inc. (MYGN) Sues Ambry Genetics to Thwart Rival Cancer Test
7/10/2013 8:13:45 AM
More...
|
Ambry Genetics Launches BRCA1/2: Single Genes and NGS Panel Offerings
6/14/2013 10:20:06 AM
More...
|
Ambry Genetics Launches FFPE Somatic Variant Profiling Services Developed in Collaboration With Illumina, Inc. (ILMN)
4/4/2013 11:31:34 AM
More...
|
|